Answers are grounded in this paper and cite their sources.
We compared the efficacies of liposomal amphotericin B (LAmB) and an amphotericin B lipid complex (ABLC) in diabetic ketoacidotic (DKA) or neutropenic mice with disseminated zygomycosis. ABLC was as effective as LAmB in neutropenic but not DKA mice. Low-dose ABLC was less effective than LAmB at reducing brain fungal burdens in both models.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: